Trade Summary

4 days ago, de Boer Daniel Anton, serving as Chief Executive Officer at ProQR Therapeutics N.V. (PRQR), purchased 200,000 shares at $1.77 per share, for a total transaction value of $353,960.00. Following this transaction, de Boer Daniel Anton now holds 500,000 shares of PRQR.

This purchase represents a 66.67% increase in de Boer Daniel Anton's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, July 31, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 3, 2026 at 4:01 PM ET, 3 days after the trade was made.

ProQR Therapeutics N.V. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.